Incyte (INCY) Current Leases (2018 - 2026)
Incyte (INCY) posted Current Leases of $4.4 million for Q1 2026, down 2.28% on a QoQ basis from $4.5 million in Q4 2025, and down 1.45% year-over-year from $4.5 million in Q1 2025.
Incyte (INCY) Current Leases (2018 - 2026) Analysis & Trends
Incyte's Current Leases history runs 9 years deep, the most recent figure standing at $4.4 million for Q1 2026.
- Quarterly Current Leases fell 1.45% year-over-year to $4.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.4 million (down 1.45% YoY) and the FY2025 annual result came in at $4.5 million, up 2.2% from the prior year.
- Current Leases was $4.4 million for Q1 2026 at Incyte, down from $4.5 million in the prior quarter.
- Across five years, Current Leases topped out at $9.9 million in Q1 2022 and bottomed at $3.0 million in Q2 2022.
- A 5-year average of $4.1 million and a median of $3.9 million in 2024 frame the typical range for Current Leases.
- Peak annual rise in Current Leases reached 327.45% in 2022, while the deepest fall reached 72.39% in 2022.
- Incyte's Current Leases stood at $3.2 million in 2022, then grew by 8.18% to $3.4 million in 2023, then grew by 28.5% to $4.4 million in 2024, then rose by 2.2% to $4.5 million in 2025, then retreated by 2.28% to $4.4 million in 2026.
- Business Quant data shows INCY's Current Leases at $4.4 million in Q1 2026, $4.5 million in Q4 2025, and $4.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 531,233.95 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 20.58 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 720.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 16.61 Mn |
| 10 | Incyte | 23.47 Bn | 19.46 Bn | 1.17 Bn | 4.41 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.41 Mn |
| Dec 31, 2025 | 4.52 Mn |
| Sep 30, 2025 | 4.49 Mn |
| Jun 30, 2025 | 4.48 Mn |
| Mar 31, 2025 | 4.48 Mn |
| Dec 31, 2024 | 4.42 Mn |
| Sep 30, 2024 | 3.93 Mn |
| Jun 30, 2024 | 3.87 Mn |
| Mar 31, 2024 | 3.68 Mn |
| Dec 31, 2023 | 3.44 Mn |
| Sep 30, 2023 | 3.06 Mn |
| Jun 30, 2023 | 3.17 Mn |
| Mar 31, 2023 | 3.15 Mn |
| Dec 31, 2022 | 3.18 Mn |
| Sep 30, 2022 | 3.11 Mn |
| Jun 30, 2022 | 3.04 Mn |
| Mar 31, 2022 | 9.90 Mn |
| Dec 31, 2021 | 2.64 Mn |
| Sep 30, 2021 | 2.40 Mn |
| Jun 30, 2021 | 11.00 Mn |